IntegriChain的动态

Want visibility into how your company will likely score in an upcoming external pharmacovigilance quality audit? Let Verve Group Consulting provide you with an advanced,?internal?audit. The team at Verve Group Consulting has 20+ years of pharmacovigilance quality audit experience, from the perspective of both manufacturers and service providers. Based on a budget that works for you, we'll give you an objective report into your company's pharmacovigilance quality strengths and weaknesses. In addition, we'll help you remediate any weaknesses before your next audit. If you'd like, we'll attend the audit, provide expert context to the discussion and help you create your company's formal response. So that your overall pharmacovigilance quality audit process is proactive, we can also help update any of your existing SOPs, as well as create new ones. Verve Group Consulting was created by entrepreneurs…for entrepreneurs. We understand that our clients typically have limited operational cash and that their full-time employees are stretched thin. So, they need to devote most of their assets to measurable revenue outcomes and true inflection points. That is where we come in. We provide external, big-company expertise, on the very terms that make sense for younger companies. Even better, our deliverables help give clients a competitive advantage in the marketplace, as well as help clients to be more due-diligence friendly with regulators and investors. We are proud to say that our entrepreneurial clients control everything: budgets, turnaround time, deliverables, dial up/dial down support and everything in between. Frankly, we wouldn’t have it any other way. #pharmacovigilance #compliance #innovation #CEOmindset

Just started in a new role? Managing a new starter? Find out about the 30-60-90 day plan below and get the first 3 months on track! ?????? ?? Follow the Lead Candidate page to stay up to date with the latest jobs and happenings in the pharma and bio outsourcing space! #NewRole #NewJob #Planning

Just started in a new role? Managing a new starter? Find out about the 30-60-90 day plan below and get the first 3 months on track! ?????? ?? Follow the Lead Candidate page to stay up to date with the latest jobs and happenings in the pharma and bio outsourcing space! #NewRole #NewJob #Planning

Just started in a new role? Managing a new starter? Find out about the 30-60-90 day plan below and get the first 3 months on track! ?????? ?? Follow the Lead Candidate page to stay up to date with the latest jobs and happenings in the pharma and bio outsourcing space! #NewRole #NewJob #Planning

Just started in a new role? Managing a new starter? Find out about the 30-60-90 day plan below and get the first 3 months on track! ?????? ?? Follow the Lead Candidate page to stay up to date with the latest jobs and happenings in the pharma and bio outsourcing space! #NewRole #NewJob #Planning

Just started in a new role? Managing a new starter? Find out about the 30-60-90 day plan below and get the first 3 months on track! ?????? ?? Follow the Lead Candidate page to stay up to date with the latest jobs and happenings in the pharma and bio outsourcing space! #NewRole #NewJob #Planning

Having spent nearly twenty years working in and with Strategic Cross-Functional Key Account Management programs, observations tell me that what typically trips teams up include: - a focus primarily on the tools, rather than the people - focus on internally important KPI’s, missing the opportunity for external stakeholder alignment - &, responsibility for inputs and outputs being placed on one individual, who often lacks the decision-making authority to get stuff done These elephants in the room were identified with this group, a fantastic first step. #KAM #pharma #customerengagement

Greetings From #International_Marketing_Division of General Pharmaceuticals Ltd. We want to express gratitude to each team member for their hard work, adaptability, and problem-solving skills. Together, we’ve achieved excellence, and I’m excited about what the future holds for our department. #Key_Achievements: 1. Sells Growth: Ensured sustainable sales growth and higher profitability. 2. Streamlined Processes:?We implemented efficient filing systems, saving valuable time and enhancing productivity. 3. Event Coordination:?Successfully organized training events, fostering team spirit and collaboration. 4. Cost Savings:?Introduced innovative cost-saving procedures, contributing to our bottom line. 5. Positive Workplace Environment:?Our team’s commitment to creating a positive atmosphere has made our office a great place to work.

???????? ?????????????? ?????????? ???? ??&?? ???? ?????? ???????? ?????? ???????? ???????????? ???????????? ???? ?????????????? ?????? ???????????? Considering the current dynamics at work on CHC with all type of key players, we expect M&A to only accelerate. To address the full potential of M&A on CHC, time for all participants to improve at: i)?Integrating all available M&A learnings in the FMCG/ CHC industry over the last 15 years ii) Finely understanding their strategic framework (ownable strengths to leverage) iii) Determining granular M&A hypotheses (where-to-play/ how-to-win choices) taking into consideration the required success drivers on each segment/ market they have strategic intent on iv) Identifying the right assets & conducting rigorous due diligences v)?Determining optimal value creation cases & corresponding integration models Exciting times for M&A on CHC More on all those points in our latest publication: ???????? ????????: ???????????????? ?????? ???????? ???? ???????????????????????????? ???? ???????????????? ???????????? ???????? (??????), ?????? ?????????????? & ???????????? ?????? ?????????? ?????????????????????? ???????? ????????-???????? https://lnkd.in/eeCZYWmt To get the corresponding deck, please leave your name in comment & allow us few days ???? ?????? ?????? ?????? ????????????????, ???????????? ???? & ?????????????????? ???? ?????? ???????? ?????? ???????????????? ????????????????????: https://lnkd.in/ea4gy65y

CROSSING HIERARCHY Crossing professional hierarchy can be good or bad, depending on the context and motivations. Its how i see Good Points 1. Innovation and fresh perspectives: Bypassing traditional hierarchy can bring new ideas and approaches. 2. Efficient problem-solving: Collaborating across levels can lead to faster solutions. 3. Talent development: Giving junior team members opportunities to work with senior leaders can aid growth. 4. Building relationships: Cross-hierarchy connections can foster a sense of community and teamwork. 5. Adaptability: Flatter structures can respond quickly to changing environments. Bad Points 1. Bypassing expertise: Skipping levels can overlook valuable knowledge and experience. 2.Confusion and role ambiguity: Unclear expectations and responsibilities can arise. 3.Lack of accountability: Ignoring established hierarchy can lead to unclear lines of responsibility. 4.Resentment and demotivation: Bypassing senior team members can demotivate and create resentment. 5.Disruption of established processes: Ignoring established protocols can lead to chaos and inefficiencies. To make crossing professional hierarchy valid and win win : 1. Clearly communicate intentions and expectations. 2. Ensure collaboration, not circumvention. 3. Respect and involve relevant stakeholders. 4. Establish clear roles and responsibilities. 5.Monitor and adjust as needed. YOU CAN DECIDE BETTER ?? #growth #pharmaceuticals #pharmaceuticalindustry #pharmaceuticalsales #cadila #abbottproud #cipla #drreddys #hrbusinesspartner #merckgroup #takeda #bristolmyerssquibb #johnsonandjohnson #gskproud #astrazeneca #drreddys #intas #hrbp #hr #keyaccountmanager #internationalsales #healthcareindustry #hradmin #ceocoaching #ceo #ceomindset #corporatebusiness #corporatehospital #alkem #institutions #malaysia #saleseffectiveness #learninganddevelopment #kam #keyaccount #complianceofficer #compliancetraining #purchasemanager #healthcareinnovation #institutionsales #rocheproud #corporateaccounts #teamdevelopment #csr #compliance Adil Malia Abbott B. Braun Group BD Cipla Danone Emcure Pharmaceuticals Limited GSK GE Harvard University Boehringer Ingelheim The Janssen Pharmaceutical Companies of Johnson & Johnson Merck Merck Group